Clinical Trial: Study of Bimatoprost Gel on Eyelash Growth
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety
Brief Summary: A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
Detailed Summary:
Sponsor: Duke University
Current Primary Outcome: eyelash length [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- eyelash pigment [ Time Frame: 6 mos ]blinded grader used digital photos to grade degree of pigment on scale of 1-5
- eyelash thickness [ Time Frame: 6 mos ]blinded grader used digital photos to grade degree of thickness on scale of 1-5
- eyelash amount [ Time Frame: 6 mos ]blinded grader used digital photos to grade degree of amount by counting lashes
- eyelash side effects [ Time Frame: 6 mos ]any side effects (irritation, allergy, iop change, visual acuity, macular edema, uveitis, iris color change, etc... were assessed
Original Secondary Outcome: Same as current
Information By: Duke University
Dates:
Date Received: September 10, 2010
Date Started: February 2007
Date Completion:
Last Updated: July 14, 2014
Last Verified: September 2010